国产抗癌药再突破! 映恩生物ADC药物“赶上”罗氏同类药

每日经济新闻
Sep 09, 2025

9月8日,映恩生物- B(HK09606,股价406.4港元,市值357.78亿港元,以下简称映恩生物)开盘大涨,截至当日收盘,股价涨幅为10.90%。9月9日,公司股价继续小幅上涨。  消息面上,自9月8日起,映恩生物被恒生指数有限公司纳入恒生综合指数成分股,同时被调入沪港通下港股通标的名单。这意味着,符合资格的中国内地投资者可以通过上海证券交易所直接投资公司股票,公司的投资人结构会进一步多元化...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10